7260 93 (Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg)
Pill with imprint 7260 93 is Yellow, Elliptical / Oval and has been identified as Glyburide and metformin hydrochloride 1.25 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 7260 93
Glyburide and metformin hydrochloride
- Imprint:
- 7260 93
- Strength:
- 1.25 mg / 250 mg
- Color:
- Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
More about glyburide/metformin
- Glyburide/metformin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: antidiabetic combinations
Consumer resources
Other brands: Glucovance
Professional resources
- Glyburide and Metformin (FDA)
- Glyburide and Metformin Tablets (FDA)
- Glyburide and Metformin (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
